Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1043-21-6

Post Buying Request

1043-21-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1043-21-6 Usage

Description

Pirenoxine, also known as Piridostigmine, is a synthetic derivative of the naturally occurring alkaloid physostigmine. It is a reversible acetylcholinesterase inhibitor, which means it can temporarily increase the concentration of acetylcholine in the synaptic cleft by inhibiting its breakdown. This action leads to enhanced cholinergic transmission, making Pirenoxine a promising candidate for various medical applications.
Source:
Pirenoxine is a synthetic compound, and its production involves chemical synthesis processes.
Production Methods:
Pirenoxine is synthesized through a series of chemical reactions starting from the precursor compound, physostigmine. The synthesis process involves several steps, including protection and deprotection of functional groups, formation of the quaternary ammonium group, and purification.

Uses

Used in Ophthalmology:
Pirenoxine is used as an anti-cataract agent for the possible treatment and prevention of cataracts. It is believed to protect the lens of the eye from oxidative damage and maintain its transparency by inhibiting the formation of advanced glycation end products (AGEs) and reducing oxidative stress.
Used in Neurology:
Pirenoxine is used as a medication for the symptomatic treatment of myasthenia gravis, a neuromuscular disorder characterized by muscle weakness and fatigue. It works by increasing the concentration of acetylcholine in the synaptic cleft, thereby enhancing neuromuscular transmission and improving muscle strength.
Used in Antiviral Applications:
Pirenoxine has been found to possess antiviral properties, making it a potential candidate for the treatment and prevention of viral infections. Its antiviral activity is thought to be due to its ability to inhibit viral replication and reduce viral load in infected cells.

Check Digit Verification of cas no

The CAS Registry Mumber 1043-21-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,4 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1043-21:
(6*1)+(5*0)+(4*4)+(3*3)+(2*2)+(1*1)=36
36 % 10 = 6
So 1043-21-6 is a valid CAS Registry Number.
InChI:InChI=1/C16H8N2O5/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12/h1-6H,(H,18,19)(H,21,22)

1043-21-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,5-dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Hydroxy-pyrido-5-phenoxazon-3-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1043-21-6 SDS

1043-21-6Upstream product

1043-21-6Downstream Products

1043-21-6Related news

Interaction between Pirenoxine (cas 1043-21-6) and bovine serum albumin in aqueous solution07/23/2019

This work concerns the interaction of prenoxine sodium (PRX) and bovine serum albumin (BSA), which was conducted by spectroscopic means: fluorescence spectra, ultraviolet–visible spectra (UV–vis) and circular dichroism spectra (CD spectra) in physiological conditions. The results revealed the ...detailed

Pirenoxine (cas 1043-21-6) prevents oxidative effects of argon fluoride excimer laser irradiation in rabbit corneas: biochemical, histological and cytofluorimetric evaluations07/22/2019

The production of reactive oxygen species (ROS) associated with excimer laser irradiation is recognized as a possible cause of corneal haze following photorefractive keratectomy (PRK). Our work was aimed at investigating in vitro the oxidative effects induced by subablative laser fluences and at...detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1043-21-6